PALO ALTO, Calif., Aug. 14, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the quarter ended June 30, 2023 . “We experienced a significant setback…Read More
Kodiak Sciences Inc Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights
